J. Erika Haydu, MD, PhD

home / authors / j-erika-haydu-md-phd

Articles

B-cell lymphoma -- Image credit: Arif Biswas | stock.adobe.com

Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical Considerations

Uvette Lou, PharmD, BCOP;Brenna Rowan, PharmD, BCOP;Abigail McLaren, PharmD, MS;E. Bridget Kim, PharmD, BCPS, BCOP;Mark N. Sorial, PharmD, BCOP;J. Erika Haydu, MD, PhD;Matthew M. Lei, PharmD, BCOP
August 16th 2024

This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.

Read More

Latest Updated Articles

Chronic lymphocytic leukemia -- Image credit: LASZLO | stock.adobe.com
Published: August 19th 2024 | Updated: September 12th 2024
Chronic Lymphocytic Leukemia: A Review of Noncovalent BTK Inhibitors, Novel Agents, and Toxicity Management of BTK Inhibitors
Image Credit: © Zhanna - stock.adobe.com
Published: September 4th 2024 | Updated: September 12th 2024
Insights Into Immunotherapies For Adults With TP53-Mutated Acute Lymphoblastic Leukemia
Image Credit: © Gefo- stock.adobe.com
Published: September 7th 2024 | Updated: September 12th 2024
Expanding Treatment Horizons for Sickle Cell Disease: Barriers, Innovations, and Future Directions
X-ray of breast cancer -- Image credit: peterschreiber.media | stock.adobe.com
Published: August 28th 2024 | Updated: September 12th 2024
Pharmacists Enhance Care for Patients With HR+/HER2– Breast Cancer on CDK4/6 Inhibitor Therapy
Man receiving vaccine -- Image credit: New Africa | stock.adobe.com
Published: July 25th 2024 | Updated: September 12th 2024
Research Results Show Promise Toward Development of a Universal Influenza Vaccine
Proud mature woman smile after vaccination with bandage on arm. Beautiful smiling senior woman 70s after receiving the coronavirus vaccine. Elderly lady getting immunization via anti-viral vaccine - Image credit: Jelena Stanojkovic | stock.adobe.com
Published: August 15th 2024 | Updated: September 12th 2024
Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses